Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00771264 · ClinicalTrials.gov registry record · Phase 4
Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms
A Phase 4 study, sponsored by Uroplasty.
- Completed
- Registry status
- Phase 4
- Development phase
- 220
- Enrollment target
NCT00771264 is a Phase 4 study that has completed, run by Uroplasty. The registered enrollment target is 220 participants.
The verdict
NCT00771264, a Phase 4 study, has completed, sponsored by Uroplasty.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 220 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate superiority of percutaneous posterior tibial nerve stimulation (PTNS) therapy compared to sham therapy for the treatment of patients with overall bladder (OAB) symptoms.
Interventions
- DEVICE Urgent PC Neuromodulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2008-09 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00771264
The ClinicalTrials.gov registry entry for NCT00771264 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Uroplasty, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Urgent PC Neuromodulation System is the first listed.
NCT00771264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00771264 about?
NCT00771264 is a clinical study titled "Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms". The purpose of this study is to demonstrate superiority of percutaneous posterior tibial nerve stimulation (PTNS) therapy compared to sham therapy for the treatment of patients with overall bladder (OAB) symptoms.
What is the current status of trial NCT00771264?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 220 participants. The study started on 2008-09. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00771264?
The interventions under investigation include: Urgent PC Neuromodulation System (DEVICE).
Who is sponsoring clinical trial NCT00771264?
This trial is sponsored by Uroplasty, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.